使用卢戈碘液染色内镜早期检测头颈癌患者食管第二原发肿瘤:系统综述与荟萃分析
该系统综述与荟萃分析纳入15项研究共3386例患者,评估卢戈碘液染色内镜在头颈鳞状细胞癌(HNSCC)患者中检测食管第二原发肿瘤(SPT)的诊断率。结果显示HNSCC患者食管SPT平均检出率为15%,下咽癌(28%)或口咽癌(14%)患者患病率最高,食管SPT中49%为高级别异型增生、51%为浸润癌。作者认为有足够证据开展卢戈碘液染色内镜,尤其在亚洲患者群体中。
要点
- HNSCC患者经卢戈碘液染色内镜检出食管SPT的平均检出率为15%。
- 下咽癌(28%)或口咽癌(14%)患者食管SPT患病率最高。
- 检出的食管SPT中49%为高级别异型增生,51%为浸润癌。
核心结论
- HNSCC患者接受卢戈碘液染色内镜者中15%被诊断为食管SPT,基于此结果有足够证据开展卢戈碘液染色内镜,尤其在亚洲患者群体中。
研究设计与样本
- 系统综述与荟萃分析,检索所有可获得的数据库以查找所有卢戈碘液染色内镜筛查研究,共纳入15项研究、3386例患者。
主要发现
- HNSCC患者食管SPT的平均检出率为15%。
- 食管SPT患病率在下咽原发肿瘤患者中最高(28%),口咽原发肿瘤患者为14%。
- 食管SPT中49%被分类为高级别异型增生,51%为浸润癌。
关键数值与推荐
- HNSCC患者食管SPT平均检出率15%,下咽癌患者患病率28%,口咽癌患者患病率14%。
- 食管SPT病理分类:高级别异型增生49%,浸润癌51%。
临床怎么用
- 作者认为基于这些结果有足够证据开展卢戈碘液染色内镜,尤其在亚洲患者群体中。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Early detection of esophageal secondary primary tumors (SPTs) in head and neck squamous cell carcinoma (HNSCC) patients could increase patient survival. The purpose of this study was to determine the diagnostic yield of esophageal SPTs using Lugol chromoendoscopy. METHODS: A systematic review of all available databases was performed to find all Lugol chromoendoscopy screening studies. RESULTS: Fifteen studies with a total of 3386 patients were included. The average yield of esophageal-SPTs in patients with HNSCC was 15%. The prevalence was the highest for patients with an index hypopharyngeal (28%) or oropharyngeal (14%) tumor. The esophageal-SPTs were classified as high-grade dysplasia in 49% of the cases and as invasive carcinoma's in 51%. CONCLUSION: Our results show that 15% of the patients with HNSCC that underwent Lugol chromoendoscopy were diagnosed with an esophageal-SPT. Based on these results there is enough evidence to perform Lugol chromoendoscopy, especially in an Asian patient population.
引用
- Bugter O, van de Ven SEM, Hardillo JA, et al. Early detection of esophageal second primary tumors using Lugol chromoendoscopy in patients with head and neck cancer: A systematic review and meta-analysis. Head Neck. 2018. PMID: 30593712. doi:10.1002/hed.25548
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。